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Foreword From Editor
This proceeding consists of abstracts and full-articles of speakers 
and presenters of the Seminar and Workshop: Women And Health: 
Towards better understanding and environment for the future 
generation held from 21-24 November 2011 in the Faculty of 
Medicine – Universitas Kristen Indonesia, Jakarta. The event was 
jointly organized with Deutsch-Indonesische Gesellschaft fuer 
Medizine (DIGM) or German-Indonesian Medical Association, 
Indostaff and partly sponsored by Deutscher Akademischer 
Austausch Dients (DAAD) or German Academic Exchange Service.
With regards to the content of proceeding, not all of speakers and 
presenters sent their full paper, but even though only few of them 
sent their full paper, the proceeding is published.
Herewith the editor wish to thank all speakers and presenters who 
sent their full paper to be published in the proceeding.
Jakarta, December   2015
Abraham Simatupang 
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Foreword of DIGM
Guten Morgen sehr verehrte Damen und Herren.
Ich begruesse Sie  alle heute im Namen des DIGM-Vorstandes 
zum Seminar und Workshop Women and Health: Towards better 
understanding and environment for the future generation  recht 
herzlich 
Ich freue mich  darueber, dass Sie in so grosser Zahl die Einladung 
der Organisationscommittee unter Leitung von Herrn Dr Abraham 
gefolgt haben. Ich begruesse und bedanke mich an: (1) Schirmfrau: 
Dr. dr. Endang Rahayu Sedyaningsih, Gesundheitsministerin der 
Rep.Indonesia und unserem Schirmherr: Sein Exzelenz Botschafter 
der Bundesrepublik Deutschland Herrn Botschafter Dr Norbert Baas; 
(2) Unserer Forderer: Herrn und Frau Ir. Maruli Gultom, Rektor 
der Universiaet Kristen  Indonesia;  drAngkasa Sebayang,  Dekan 
der Med.Fakultaet UKI; dr. Rosma Napitupulu, Direktor des  UKI 
Krankenhaus; Sowie Dr H.Bucholt,Direktor DAAD Indonesia  der 
uns unterstutzt hat. Auch begrusse und danke ich unseren Gaesten 
aus Deutschland und Indonesien, allen Kollegen, Mittgliedern und 
Sympatisanten der DIGM, die unserer Einladung gefolgt haben.
Ich hoffe, dass heutiges Seminar und Workshop  die Gestaltung und 
Entwicklung der Kooperation zwischen Deutschland und Indonsien 
in Medizin beitragen kann. Das wichtigste in unserer Arbeit ist nicht 
an der Grenze des erreichten stehenzubleiben, sondern vorwarts 
mit neuen Aufgaben zu gehen. Die Zukunft von der  friedliche 
Zusammenleben unsere Bevolkerung in Indonesien und die 
Kooperation beide Laendern zwischen Indonesien und Deutschland 
haengen davon ab, woran wir denken und was wir heute machen.
Herzlichen dank.
Prof. Dr.med. dr.Rasyid Soeparwata, Spb.,Sp.B(K)V, Sp.BTKV(K)
iii
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Foreword of the Dean- 
Faculty of Medicine
HE Minister of People’s Welfare of the Republic of Indonesia, dr. Agung Laksono,
HE Ambassador of the Republic of Germany, Dr. Norbert Baas
Director of DAAD, Dr. H. Buchholt
Presidents of the German Indonesian Medical Association (DIGM)
Dean of the Medical Faculty, dr. Angkasa Sebayang, MS
Speakers from Indonesia and also overseas,
Dear participants,
We heartily welcome you to our seminar and workshop entitled: Women 
and health: towards a better understanding and environment for the 
future generation”. The seminar is organised in commemorating the 49th 
anniversary of our faculty of medicine.
The faculty of medicine of UKI is one amongst the pioneers of medical 
faculties established by private universities in Indonesia, and to date there 
are 72 medical faculties which are spread from Aceh to Papua. The alumni 
of the faculty of medicine is 3,524 with several speciliaties, expertise and 
positions they posses, and one of the alumni is the Coordinating Minister for 
People’s Welfare, HE, dr. Agung Laksono. There are three others alumni in 
the House of Parliament and they are actively involved in the development 
of health system in Indonesia. The rest of the alumni are practicing what 
they have learned from our campus, giving their best to the community.
In our strategic planning, we decided that the faculty medicine will focus on 
tropical medicine and traumatology. We have embedded these two subjects 
into our curriculum and soon the research activities and community service 
program should also focus in these subjects. Recently we received an 
electron microscope from the government, and this will also accelerate us 
in realising the objectives of our faculty. 
On behalf of our faculty, I would like to thank you the organizing committee, 
German Indonesian Medical Association and DAAD for their hard works 
and supports that has made this event possible.
Angkasa Sebayang, dr., MS.
v
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Foreword of the Rector of UKI
HE Minister of People’s Welfare of the Republic of Indonesia, dr. Agung Laksono,
HE Ambassador of the Republic of Germany
Director of DAAD, Dr. H. Buchholt
Presidents of the German Indonesian Medical Association (DIGM)
Dean of the Medical Faculty, dr. Angkasa Sebayang, MS
Speakers from Indonesia and also overseas,
Dear participants,
First of all, I would like to welcome you all to our campus, Universitas 
Kristen Indonesia– with its motto: “To serve, not to be served.”  Our 
university serves the community as higher education institution that serves 
this nation with knowledge, expertise and services into the community.
We practice Tri Dharma Perguruan Tinggi, the three pillars of higher 
education in Indonesia--teaching, research and community service for 57 
years as partner of the government to provide higher education service 
to the people of Indonesia. We have now more than 30.000 alumni who 
contribute significantly to the development of the people and the country.
We would also like to mention our special friendship with Germany. UKI 
has a long and strategic cooperation with Germany  from the beginning of 
establishment of our university, both infrastructure and capacity building. 
Many of our lecturers, especailly those of faculty of engineering and the 
faculty of medicine went to Germany for their  graduate and post-graduate 
studies, supported by among others, Evangelische Entwicklung Dienst- 
Church Development Service (EED) and  German Academic Exchange 
Service (DAAD). 
Dear colleagues and participants,
In this opportunity, on behalf of UKI, I would like to thank the organizing 
committee, DAAD, German-Indonesian Medical Association for organizing 
the seminar which focuses on very important issue “women and health: 
towards a better understanding and environment for the future generation”. 
Also, I thank all speakers and contributors who will share and discuss their 
knowledge on this issue. To all overseas speakers, I hope you enjoy your 
short stay in Jakarta and I suggest you also to visit other parts of Indonesia, 
especially Komodo Island, because the Komodo (the giant lizard) has been 
recently recognised as the new seven wonders of the world! Last but not 
least, I wish you all for a succesful seminar and workshop.
Ir. Maruli Gultom  
vii
aGo buku uki.indd   7 1/23/2016   5:09:26 PM
aGo buku uki.indd   8 1/23/2016   5:09:26 PM
Table of Content 
1. Foreword from Editor ................................................................. i 
2. Foreword of DIGM ..................................................................... ii
3. Foreword of the Dean- Faculty of Medicine .............................. v
4. Foreword of the Rector of UKI .................................................. vii
5. Table of Content ......................................................................... ix
6. Program  of the seminar cum workshop ..................................... 1
7. Term of Reference DIGM - GIMA ............................................. 7
8. Abstracts of Symposium & Posters ...........................................  15
9. Sex-linked Effects of Pharmacotherapy ....................................  41
10. Effect of Corn Silk (Zea Mays L.) On Gentamicin-Piroxicam   
Induced Renal Dysfunction In Rats ...........................................  49
11. Schizophrenia and other psychotic disorders Luana N.A ..........  61
12. Description of “Taboo” Food Pattern of Pregnant Women With   
Chronic Energy Deficiency at Kaliakah Primary Health Care,     
Jembrana- Bali Province ............................................................  73
13. Implication of Duffy Binding-Like Domain (DBL) that Bind    
Chondroitin Sulfate A (CSA) against Pregnancy-Associated    
 Malaria (PAM) ...........................................................................  83
14. Review of Lupus Nephritis ........................................................  91
15.  “Close The Door and Do The Job” – Findings From A Case    
Study On South African Rural Black Women’s Sexual Agency.. 101
16.  Metabolic complications in women living with HIV/AIDS ......  111
17. Peritoneal (Dry Type) And Small Bowel Tuberculosis among  
Female  Patients With ................................................................. 121
18. Roles and Functions of The Placenta .........................................  129
19. INDOSTAFF Forum: Women in Education ...............................  139
ix
aGo buku uki.indd   9 1/23/2016   5:09:26 PM
aGo buku uki.indd   10 1/23/2016   5:09:26 PM
Pr
og
ra
m
 
Se
m
in
ar
 c
um
 W
or
ks
ho
p:
  
W
om
en
 A
nd
 H
ea
lth
: T
ow
ar
ds
 b
et
te
r 
un
de
rs
ta
nd
in
g 
an
d 
en
vi
ro
nm
en
t f
or
 th
e 
fu
tu
re
 g
en
er
at
io
n 
21
-2
5 
N
ov
em
be
r 
20
11
 
 
D
A
TE
 
T
IM
E
 
P 
R
 O
 G
 R
 A
 M
 
Su
nd
ay
,  
20
 N
ov
 
09
.0
0-
19
.0
0 
A
rr
iv
al
 o
f  
fo
re
ig
n 
sp
ea
ke
rs
  
19
.0
0-
21
.0
0 
W
el
co
m
e 
di
nn
er
  (
H
os
t: 
D
IG
M
-J
ak
ar
ta
) 
S 
e 
m
 i 
n 
a 
r 
M
on
da
y,
  
21
 N
ov
 
08
:0
0-
09
:0
0 
R
eg
is
tra
tio
n 
09
:0
0-
09
:4
5 
O
pe
ni
ng
 c
er
em
on
y:
 
1.
 
O
rg
an
iz
in
g 
C
om
m
itt
ee
 
2.
 
R
ec
to
r o
f U
K
I 
3.
 
D
IG
M
 
4.
 
D
A
A
D
-J
ak
ar
ta
 O
ff
ic
e 
In
tro
du
ct
or
y 
R
em
ar
ks
: M
s. 
Ju
di
th
 S
oe
ry
ad
ja
ya
 
K
ey
no
te
 sp
ee
ch
: C
oo
rd
in
at
in
g 
M
in
is
te
r f
or
 P
eo
pl
e’
s w
el
fa
re
, H
.E
. d
r. 
A
gu
ng
 L
ak
so
no
 
09
:4
5-
10
.0
0 
C
of
fe
e 
br
ea
k 
&
 P
re
ss
 c
on
fe
re
nc
e 
10
.0
0-
12
.0
0 
POSTER  SESSION 
Sy
m
po
si
um
 I:
 
G
en
de
r s
pe
ci
fic
 d
is
ea
se
s –
 a
re
 th
ey
 re
al
? 
  
M
od
er
at
or
: D
r.m
ed
. A
br
ah
am
 S
im
at
up
an
g,
 d
r.,
 M
K
es
. 
1.
 G
en
de
r s
pe
ci
fic
 in
flu
en
ce
 o
f t
he
 d
ie
t o
n 
ch
ol
es
te
ro
l a
bs
or
pt
io
n 
an
d 
pl
as
m
a 
ch
ol
es
te
ro
l l
ev
el
s  
(P
ro
f. 
D
r. 
D
. L
ue
tjo
ha
nn
, U
ni
ve
rs
ity
 o
f B
on
n,
 G
er
m
an
y)
 
2.
 H
ig
hl
ig
ht
 o
n 
ve
no
us
 th
ro
m
bo
em
bo
lis
m
: a
 g
en
de
r  
is
su
e?
  (
Pr
of
. D
r.m
ed
. R
 S
oe
pa
rw
at
a 
– 
D
IG
M
, 
R
SC
M
-F
K
 U
I)
 
3.
 E
ar
ly
 d
et
ec
tio
n 
of
 b
re
as
t c
an
ce
r (
En
os
 H
. S
ib
ur
ia
n,
 d
r.,
 S
pB
, S
pB
O
nk
. –
 R
S 
U
K
I)
 
4.
 A
nt
io
xi
da
nt
 a
nd
 Im
m
un
om
od
ul
at
io
n 
C
ap
ac
ity
 o
f S
om
e 
C
om
m
on
 F
oo
d 
C
om
m
od
iti
es
 
R
ep
re
se
nt
in
g 
Fu
nc
tio
na
l F
oo
ds
 (P
ro
f. 
D
r. 
Ir
. F
ra
ns
is
ka
 R
un
gk
at
-Z
ak
ar
ia
, I
PB
) 
12
.0
0-
 1
3.
30
 
Lu
nc
h 
Sy
m
po
si
um
—
C
er
vi
ca
l C
an
ce
r (
G
la
xo
-S
m
ith
 &
 K
lin
e)
 
Proceeding Seminar
Women & Health: Towards a better understanding and environment for the future 1
aGo buku uki.indd   1 1/23/2016   5:09:26 PM
Pr
og
ra
m
 
Se
m
in
ar
 c
um
 W
or
ks
ho
p:
  
W
om
en
 A
nd
 H
ea
lth
: T
ow
ar
ds
 b
et
te
r 
un
de
rs
ta
nd
in
g 
an
d 
en
vi
ro
nm
en
t f
or
 th
e 
fu
tu
re
 g
en
er
at
io
n 
21
-2
5 
N
ov
em
be
r 
20
11
 
 
D
A
TE
 
T
IM
E
 
P 
R
 O
 G
 R
 A
 M
 
Su
nd
ay
,  
20
 N
ov
 
09
.0
0-
19
.0
0 
A
rr
iv
al
 o
f  
fo
re
ig
n 
sp
ea
ke
rs
  
19
.0
0-
21
.0
0 
W
el
co
m
e 
di
nn
er
  (
H
os
t: 
D
IG
M
-J
ak
ar
ta
) 
S 
e 
m
 i 
n 
a 
r 
M
on
da
y,
  
21
 N
ov
 
08
:0
0-
09
:0
0 
R
eg
is
tra
tio
n 
09
:0
0-
09
:4
5 
O
pe
ni
ng
 c
er
em
on
y:
 
1.
 
O
rg
an
iz
in
g 
C
om
m
itt
ee
 
2.
 
R
ec
to
r o
f U
K
I 
3.
 
D
IG
M
 
4.
 
D
A
A
D
-J
ak
ar
ta
 O
ff
ic
e 
In
tro
du
ct
or
y 
R
em
ar
ks
: M
s. 
Ju
di
th
 S
oe
ry
ad
ja
ya
 
K
ey
no
te
 sp
ee
ch
: C
oo
rd
in
at
in
g 
M
in
is
te
r f
or
 P
eo
pl
e’
s w
el
fa
re
, H
.E
. d
r. 
A
gu
ng
 L
ak
so
no
 
09
:4
5-
10
.0
0 
C
of
fe
e 
br
ea
k 
&
 P
re
ss
 c
on
fe
re
nc
e 
10
.0
0-
12
.0
0 
POSTER  SESSION 
Sy
m
po
si
um
 I:
 
G
en
de
r s
pe
ci
fic
 d
is
ea
se
s –
 a
re
 th
ey
 re
al
? 
  
M
od
er
at
or
: D
r.m
ed
. A
br
ah
am
 S
im
at
up
an
g,
 d
r.,
 M
K
es
. 
1.
 G
en
de
r s
pe
ci
fic
 in
flu
en
ce
 o
f t
he
 d
ie
t o
n 
ch
ol
es
te
ro
l a
bs
or
pt
io
n 
an
d 
pl
as
m
a 
ch
ol
es
te
ro
l l
ev
el
s  
(P
ro
f. 
D
r. 
D
. L
ue
tjo
ha
nn
, U
ni
ve
rs
ity
 o
f B
on
n,
 G
er
m
an
y)
 
2.
 H
ig
hl
ig
ht
 o
n 
ve
no
us
 th
ro
m
bo
em
bo
lis
m
: a
 g
en
de
r  
is
su
e?
  (
Pr
of
. D
r.m
ed
. R
 S
oe
pa
rw
at
a 
– 
D
IG
M
, 
R
SC
M
-F
K
 U
I)
 
3.
 E
ar
ly
 d
et
ec
tio
n 
of
 b
re
as
t c
an
ce
r (
En
os
 H
. S
ib
ur
ia
n,
 d
r.,
 S
pB
, S
pB
O
nk
. –
 R
S 
U
K
I)
 
4.
 A
nt
io
xi
da
nt
 a
nd
 Im
m
un
om
od
ul
at
io
n 
C
ap
ac
ity
 o
f S
om
e 
C
om
m
on
 F
oo
d 
C
om
m
od
iti
es
 
R
ep
re
se
nt
in
g 
Fu
nc
tio
na
l F
oo
ds
 (P
ro
f. 
D
r. 
Ir
. F
ra
ns
is
ka
 R
un
gk
at
-Z
ak
ar
ia
, I
PB
) 
12
.0
0-
 1
3.
30
 
Lu
nc
h 
Sy
m
po
si
um
—
C
er
vi
ca
l C
an
ce
r (
G
la
xo
-S
m
ith
 &
 K
lin
e)
 
Women & Health: Towards a better understanding and environment for the future
Proceeding Seminar
2
aGo buku uki.indd   2 1/23/2016   5:09:26 PM
Pr
og
ra
m
 
Se
m
in
ar
 c
um
 W
or
ks
ho
p:
  
W
om
en
 A
nd
 H
ea
lth
: T
ow
ar
ds
 b
et
te
r 
un
de
rs
ta
nd
in
g 
an
d 
en
vi
ro
nm
en
t f
or
 th
e 
fu
tu
re
 g
en
er
at
io
n 
21
-2
5 
N
ov
em
be
r 
20
11
 
 
D
A
TE
 
T
IM
E
 
P 
R
 O
 G
 R
 A
 M
 
Su
nd
ay
,  
20
 N
ov
 
09
.0
0-
19
.0
0 
A
rr
iv
al
 o
f  
fo
re
ig
n 
sp
ea
ke
rs
  
19
.0
0-
21
.0
0 
W
el
co
m
e 
di
nn
er
  (
H
os
t: 
D
IG
M
-J
ak
ar
ta
) 
S 
e 
m
 i 
n 
a 
r 
M
on
da
y,
  
21
 N
ov
 
08
:0
0-
09
:0
0 
R
eg
is
tra
tio
n 
09
:0
0-
09
:4
5 
O
pe
ni
ng
 c
er
em
on
y:
 
1.
 
O
rg
an
iz
in
g 
C
om
m
itt
ee
 
2.
 
R
ec
to
r o
f U
K
I 
3.
 
D
IG
M
 
4.
 
D
A
A
D
-J
ak
ar
ta
 O
ff
ic
e 
In
tro
du
ct
or
y 
R
em
ar
ks
: M
s. 
Ju
di
th
 S
oe
ry
ad
ja
ya
 
K
ey
no
te
 sp
ee
ch
: C
oo
rd
in
at
in
g 
M
in
is
te
r f
or
 P
eo
pl
e’
s w
el
fa
re
, H
.E
. d
r. 
A
gu
ng
 L
ak
so
no
 
09
:4
5-
10
.0
0 
C
of
fe
e 
br
ea
k 
&
 P
re
ss
 c
on
fe
re
nc
e 
10
.0
0-
12
.0
0 
POSTER  SESSION 
Sy
m
po
si
um
 I:
 
G
en
de
r s
pe
ci
fic
 d
is
ea
se
s –
 a
re
 th
ey
 re
al
? 
  
M
od
er
at
or
: D
r.m
ed
. A
br
ah
am
 S
im
at
up
an
g,
 d
r.,
 M
K
es
. 
1.
 G
en
de
r s
pe
ci
fic
 in
flu
en
ce
 o
f t
he
 d
ie
t o
n 
ch
ol
es
te
ro
l a
bs
or
pt
io
n 
an
d 
pl
as
m
a 
ch
ol
es
te
ro
l l
ev
el
s  
(P
ro
f. 
D
r. 
D
. L
ue
tjo
ha
nn
, U
ni
ve
rs
ity
 o
f B
on
n,
 G
er
m
an
y)
 
2.
 H
ig
hl
ig
ht
 o
n 
ve
no
us
 th
ro
m
bo
em
bo
lis
m
: a
 g
en
de
r  
is
su
e?
  (
Pr
of
. D
r.m
ed
. R
 S
oe
pa
rw
at
a 
– 
D
IG
M
, 
R
SC
M
-F
K
 U
I)
 
3.
 E
ar
ly
 d
et
ec
tio
n 
of
 b
re
as
t c
an
ce
r (
En
os
 H
. S
ib
ur
ia
n,
 d
r.,
 S
pB
, S
pB
O
nk
. –
 R
S 
U
K
I)
 
4.
 A
nt
io
xi
da
nt
 a
nd
 Im
m
un
om
od
ul
at
io
n 
C
ap
ac
ity
 o
f S
om
e 
C
om
m
on
 F
oo
d 
C
om
m
od
iti
es
 
R
ep
re
se
nt
in
g 
Fu
nc
tio
na
l F
oo
ds
 (P
ro
f. 
D
r. 
Ir
. F
ra
ns
is
ka
 R
un
gk
at
-Z
ak
ar
ia
, I
PB
) 
12
.0
0-
 1
3.
30
 
Lu
nc
h 
Sy
m
po
si
um
—
C
er
vi
ca
l C
an
ce
r (
G
la
xo
-S
m
ith
 &
 K
lin
e)
 
 
13
.3
0-
15
.0
0 
Sy
m
po
si
um
 II
:  
T
he
 F
ut
ur
e 
of
 M
ed
ic
al
 S
ci
en
ce
 a
nd
 
H
ea
lth
 S
er
vi
ce
s:
 
M
od
er
at
or
: S
ah
al
a 
Pa
ng
ga
be
an
, d
r.,
 S
pP
D
, 
K
G
H
 
 D
r.m
ed
. I
nd
w
ia
ni
 A
st
ut
i, 
Sp
FK
 (U
G
M
), 
 
1.
 P
ro
f. 
D
r. 
m
ed
. T
ri 
H
an
gg
on
o 
A
ch
m
ad
-
(U
np
ad
) 
2.
 R
iz
ki
e 
Pr
as
et
yo
, d
r. 
(F
K
 U
K
I)
 
3.
 D
r. 
B
uc
hh
ol
t (
D
A
A
D
) 
Se
m
in
ar
 I:
 
R
ol
e 
of
 w
om
en
 in
 H
ea
lth
 Im
pr
ov
em
en
t M
od
er
at
or
: 
B
er
na
de
th
a,
 N
ad
ea
k,
 d
r.,
 M
Pd
.K
ed
.: 
 
1.
 V
irg
in
ity
 a
nd
 h
ea
lth
 o
f r
ep
ro
du
ct
io
n 
or
ga
n 
(W
om
en
’s
 st
ru
gg
le
 in
 k
ee
pi
ng
 th
ei
r h
ea
lth
 a
nd
 
m
or
al
 v
al
ue
s i
n 
pa
tri
ar
ch
al
 so
ci
et
y)
: D
r. 
B
ill
y 
K
 
Sa
rw
on
o 
(F
is
ip
 U
I)
 
2.
 W
om
en
 in
 so
ci
al
 a
ct
iv
iti
es
: J
ud
ith
 S
oe
ry
ad
ja
ya
  
3.
 W
om
en
 in
 re
se
ar
ch
 a
nd
 in
no
va
tio
n:
 P
ro
f. 
D
r. 
Fr
an
si
sk
a 
Za
ka
ria
-R
un
gk
at
 
 
15
.0
0-
15
.3
0 
POSTER 
 SESSION 
C
of
fe
e 
B
re
ak
 
 
15
.3
0-
17
.0
0 
Fr
ee
 O
ra
l P
re
se
nt
at
io
n 
V
en
ue
: A
ud
ito
riu
m
 
M
od
er
at
or
: S
ri 
U
da
ne
ni
, d
r.,
 M
S,
 S
pM
K
 
2.
 Y
un
us
 T
an
gg
o,
 S
pP
D
, P
h.
D
 (F
K
 U
K
I)
 
3.
 L
ua
na
 N
an
tin
gk
as
eh
, S
pK
J (
FK
 U
K
I)
 
4.
 P
ra
tiw
i M
B
io
m
ed
 (F
K
 U
K
I)
 
5.
 M
es
ta
 L
im
bo
ng
, M
Ps
i. 
(F
K
IP
-U
K
I)
 
 
V
en
ue
: 8
th
 fl
oo
r 
M
od
er
at
or
:D
r.M
ul
ya
di
 D
jo
jo
sa
pu
tro
, M
S 
1.
 S
ah
al
a 
Pa
ng
ga
be
an
, d
r.,
 S
pP
D
, K
G
H
  (
FK
 U
K
I)
 
3.
 B
on
a 
Si
m
an
un
gk
al
it,
 d
r.,
 D
H
SM
, M
K
es
. 
4.
 L
ev
in
a 
Fe
rd
ia
na
 (I
TB
) 
5.
 L
uh
 S
er
i A
ni
 (U
ni
ve
rs
ita
s U
da
ya
na
) 
6.
 D
r.m
ed
. A
br
ah
am
 S
im
at
up
an
g,
 d
r.,
 M
K
es
. (
FK
 
U
K
I)
  
 
D
A
TE
 
T
IM
E
 
P 
R
 O
G
 R
 A
 M
 
Tu
es
da
y,
 
 2
2 
N
ov
 
08
.3
0-
09
.3
0 
POSTER  
SESSION 
Se
m
in
ar
 II
: S
ki
n 
H
ea
lth
 &
 B
ea
ut
y 
M
od
er
at
or
: d
r. 
To
m
m
y 
Ti
lu
at
a,
 S
p.
B
TK
V
 
1.
 
Te
ch
ni
qu
es
 a
nd
 S
af
et
y 
of
 F
ac
el
ift
 S
ur
ge
ry
  
(d
r. 
A
go
 H
ar
lim
, M
A
R
S,
 S
pK
K
.) 
2.
 
M
an
ag
em
en
t 
of
 A
cn
e 
(d
r. 
V
ita
lis
 P
rib
ad
i, 
Sp
K
K
, M
K
es
.-F
K
 U
K
I)
 
 
Se
m
in
ar
 II
I:
 N
ew
 tr
ea
tm
en
t o
f b
re
as
t c
an
ce
r 
(E
IS
A
I)
 
09
:3
0-
10
.0
0 
C
of
fe
e 
br
ea
k 
Proceeding Seminar
Women & Health: Towards a better understanding and environment for the future 3
aGo buku uki.indd   3 1/23/2016   5:09:26 PM
10
.0
0-
12
.0
0 
Se
m
in
ar
 IV
:  
B
io
-N
eu
ro
-P
sy
ch
o-
ph
ys
io
lo
gi
ca
l a
sp
ec
ts
 o
f 
w
om
en
 M
od
er
at
or
: P
ro
f. 
D
r.r
er
.m
ed
. –
ha
bi
l H
J 
Fr
ei
sl
eb
en
: 
1.
 D
o 
w
om
en
 th
in
k 
an
d 
fe
el
 d
iff
er
en
tly
? 
(D
r. 
M
ar
tin
a 
W
iw
ie
) 
2.
 M
en
op
au
se
-r
el
at
ed
 d
is
ea
se
s (
D
r. 
Ja
n 
Pu
rb
a,
 
Ph
D
) 
3.
 P
er
ito
ne
al
 (d
ry
 ty
pe
) a
nd
 S
m
al
l B
ow
el
 
Tu
be
rc
ul
os
is
 A
m
on
g 
Fe
m
al
e 
Pa
tie
nt
s w
ith
 
Ps
yc
hi
at
ric
 D
is
or
de
rs
 (M
ar
ia
 G
or
et
ti 
A
m
at
em
bu
n,
 d
r.,
 S
pP
D
) 
4.
 M
et
ab
ol
ic
 c
om
pl
ic
at
io
ns
 in
 w
om
en
 li
vi
ng
 w
ith
 
H
IV
/A
ID
S 
 (E
rik
a 
Fe
rr
ar
i R
af
ae
l d
a 
Si
lv
a 
M
D
, P
hD
) 
Pa
ne
l d
is
cu
ss
io
n:
 
Th
e 
em
er
ge
nc
e 
of
 H
IV
 &
 A
ID
S:
 A
re
 w
om
en
 
ne
gl
ec
te
d?
 (M
od
er
at
or
: P
ro
f. 
D
r. 
R
et
no
 
W
ah
yu
ni
ng
si
h,
 S
pP
ar
K
lin
) 
 
1.
 A
yi
e 
Sr
ik
ar
tik
a,
 M
D
 (R
S 
M
ar
zu
ki
 M
ah
di
, B
og
or
) 
2.
 N
ur
la
n 
Si
lit
on
ga
, M
D
 (A
ng
sa
 M
er
ah
 F
ou
nd
at
io
n)
 
3.
 D
r. 
B
rit
ta
 
Th
eg
e 
G
er
m
an
 
&
 
So
ut
h 
A
fr
ic
an
 
pe
rs
pe
ct
iv
e 
(W
om
en
 S
tu
dy
 –
 U
ni
v 
of
 A
pp
lie
d 
Sc
ie
nc
e,
 K
ie
l) 
 
12
.0
0-
 1
3.
30
 
Lu
nc
h 
D
A
TE
 
T
IM
E
 
P 
R
 O
 G
 R
 A
 M
 
 
13
.3
0-
15
.3
0 
POSTER SESSION 
W
om
en
 in
 H
ea
lth
: F
ro
m
 B
io
m
ed
ic
al
 to
 
C
lin
ic
al
 A
sp
ec
ts
.  
M
od
er
at
or
: P
ro
f. 
R
on
da
ng
 S
oe
gi
an
to
-S
ia
gi
an
, 
Ph
D
 
1.
 
Ep
ig
en
et
ic
 c
on
tro
l 
on
 m
at
er
na
l 
he
al
th
 (
D
r. 
Tr
in
a 
Ta
lle
i-U
ns
ra
t) 
2.
 
R
ol
e 
of
 U
SG
 i
n 
O
bs
te
tri
c 
C
ar
e 
to
 R
ed
uc
e 
M
at
er
na
l 
M
or
ta
lit
y 
R
at
e 
an
d 
Pe
rin
at
al
 
M
or
ta
lit
y 
R
at
e 
(P
ro
f. 
D
r. 
I. 
O
. M
ar
si
s, 
Sp
O
G
-
FK
 U
K
I)
 
3.
 
O
pp
or
tu
ni
st
ic
 I
nf
ec
tio
n 
in
 A
ID
S:
 i
m
pa
ct
 o
n 
th
e 
 
liv
es
 
of
 
w
om
en
 
(P
ro
f. 
D
r. 
R
et
no
 
W
ah
yu
ni
ng
si
h,
 S
pP
ar
K
lin
.-F
K
 U
K
I)
 
4.
 
C
ur
en
t 
M
an
ag
em
en
t 
Th
er
ap
y 
in
 
B
re
as
t 
C
an
ce
r: 
Th
e 
R
ol
e 
of
 
PE
T 
C
T 
an
d 
R
ad
io
th
er
ap
y 
w
ith
 R
A
PI
D
 A
R
C
 (
dr
. 
Fi
el
da
 
D
ju
ita
, S
pR
 a
nd
 d
r. 
B
as
uk
i H
id
ay
at
, S
pK
N
) 
R
ep
ro
du
ct
iv
e 
H
ea
lth
 a
nd
 F
am
ily
 P
la
nn
in
g:
 
N
at
io
na
l P
op
ul
at
io
n 
an
d 
Fa
m
ily
 P
la
nn
in
g 
Bo
ar
d 
(B
K
K
BN
) 
M
od
er
at
or
: J
an
ua
r 
Si
m
at
up
an
g,
 S
pO
G
 
1.
 G
ra
nd
 d
es
ig
n 
of
 f
am
ily
 p
la
nn
in
g 
(d
r. 
Po
pp
y 
Ir
aw
at
i, 
M
PH
) 
2.
 C
om
pl
ic
at
io
ns
 d
ur
in
g 
de
liv
er
y 
ba
se
d 
on
 I
D
H
S 
20
07
 (d
r. 
N
ia
 R
ev
ia
ni
, M
A
PS
) 
 
Women & Health: Towards a better understanding and environment for the future
Proceeding Seminar
4
aGo buku uki.indd   4 1/23/2016   5:09:26 PM
 
 
15
.3
0-
16
.0
0 
 
C
lo
si
ng
 c
er
em
on
y 
 
   W
 o
 r
 k
 s 
h 
o 
p 
 W
ed
ne
sd
ay
, 
23
 N
ov
  
08
:3
0-
12
.3
0 
W
or
ks
ho
p 
1:
  
H
ow
 to
 d
ev
el
op
 a
 g
en
de
r-
se
ns
iti
ve
 h
ea
lth
 p
ro
gr
am
 in
 p
oo
r-
se
tti
ng
 a
re
as
. 
Fa
ci
lit
at
or
s:
  
1.
 D
r. 
B
rit
ta
 T
he
ge
 (C
en
te
r o
f W
om
en
 S
tu
dy
 –
 U
ni
v 
of
 A
pp
lie
d 
Sc
ie
nc
e,
 K
ie
l) 
2.
 A
lp
hi
nu
s K
am
bo
dj
i, 
M
D
 (A
ID
S 
C
om
m
itt
ee
 –
 In
do
ne
si
an
 C
ou
nc
il 
of
 C
hu
rc
he
s)
  
3.
 E
vi
 D
ou
re
n,
 M
D
 
12
.3
0-
13
.3
0 
Lu
nc
h 
12
.3
0-
16
.0
0 
H
ow
 to
 d
ev
el
op
 a
 g
en
de
r-
se
ns
iti
ve
 h
ea
lth
 p
ro
gr
am
 in
 p
oo
r-
se
tti
ng
 a
re
as
. 
 
D
A
TE
 
T
IM
E
 
P 
R
 O
 G
 R
 A
 M
 
Th
ur
sd
ay
, 
24
 N
ov
 
08
:3
0-
12
.0
0 
W
or
ks
ho
p 
2:
 K
eg
el
 
ex
er
ci
se
 to
 st
re
ng
th
en
 th
e 
pe
lv
ic
 m
uc
le
s o
f 
m
ul
tip
ar
a 
w
om
en
 
(F
ac
ili
ta
to
rs
: D
ra
 S
ri 
K
us
tin
i S
ST
 F
t, 
M
 F
is
. a
nd
 
M
ak
si
m
us
 B
is
a,
 S
St
FT
, 
SK
M
)  
W
or
ks
ho
p 
3:
 
D
em
on
st
ra
tio
n:
 T
at
to
o-
re
m
ov
al
 
(F
ac
ili
ta
to
r: 
dr
. A
go
 H
ar
lim
, 
Sp
K
K
, M
A
R
S)
 
     A
rr
iv
al
 o
f I
nd
os
ta
ff
 F
or
um
 P
ar
tic
ip
an
ts
 
 
12
.3
0-
13
.3
0 
Lu
nc
h 
 
13
.3
0-
18
.0
0 
In
do
st
af
f F
or
um
* 
 
10
.0
0-
12
.0
0 
Se
m
in
ar
 IV
:  
B
io
-N
eu
ro
-P
sy
ch
o-
ph
ys
io
lo
gi
ca
l a
sp
ec
ts
 o
f 
w
om
en
 M
od
er
at
or
: P
ro
f. 
D
r.r
er
.m
ed
. –
ha
bi
l H
J 
Fr
ei
sl
eb
en
: 
1.
 D
o 
w
om
en
 th
in
k 
an
d 
fe
el
 d
iff
er
en
tly
? 
(D
r. 
M
ar
tin
a 
W
iw
ie
) 
2.
 M
en
op
au
se
-r
el
at
ed
 d
is
ea
se
s (
D
r. 
Ja
n 
Pu
rb
a,
 
Ph
D
) 
3.
 P
er
ito
ne
al
 (d
ry
 ty
pe
) a
nd
 S
m
al
l B
ow
el
 
Tu
be
rc
ul
os
is
 A
m
on
g 
Fe
m
al
e 
Pa
tie
nt
s w
ith
 
Ps
yc
hi
at
ric
 D
is
or
de
rs
 (M
ar
ia
 G
or
et
ti 
A
m
at
em
bu
n,
 d
r.,
 S
pP
D
) 
4.
 M
et
ab
ol
ic
 c
om
pl
ic
at
io
ns
 in
 w
om
en
 li
vi
ng
 w
ith
 
H
IV
/A
ID
S 
 (E
rik
a 
Fe
rr
ar
i R
af
ae
l d
a 
Si
lv
a 
M
D
, P
hD
) 
Pa
ne
l d
is
cu
ss
io
n:
 
Th
e 
em
er
ge
nc
e 
of
 H
IV
 &
 A
ID
S:
 A
re
 w
om
en
 
ne
gl
ec
te
d?
 (M
od
er
at
or
: P
ro
f. 
D
r. 
R
et
no
 
W
ah
yu
ni
ng
si
h,
 S
pP
ar
K
lin
) 
 
1.
 A
yi
e 
Sr
ik
ar
tik
a,
 M
D
 (R
S 
M
ar
zu
ki
 M
ah
di
, B
og
or
) 
2.
 N
ur
la
n 
Si
lit
on
ga
, M
D
 (A
ng
sa
 M
er
ah
 F
ou
nd
at
io
n)
 
3.
 D
r. 
B
rit
ta
 
Th
eg
e 
G
er
m
an
 
&
 
So
ut
h 
A
fr
ic
an
 
pe
rs
pe
ct
iv
e 
(W
om
en
 S
tu
dy
 –
 U
ni
v 
of
 A
pp
lie
d 
Sc
ie
nc
e,
 K
ie
l) 
 
12
.0
0-
 1
3.
30
 
Lu
nc
h 
D
A
TE
 
T
IM
E
 
P 
R
 O
 G
 R
 A
 M
 
 
13
.3
0-
15
.3
0 
POSTER SESSION 
W
om
en
 in
 H
ea
lth
: F
ro
m
 B
io
m
ed
ic
al
 to
 
C
lin
ic
al
 A
sp
ec
ts
.  
M
od
er
at
or
: P
ro
f. 
R
on
da
ng
 S
oe
gi
an
to
-S
ia
gi
an
, 
Ph
D
 
1.
 
Ep
ig
en
et
ic
 c
on
tro
l 
on
 m
at
er
na
l 
he
al
th
 (
D
r. 
Tr
in
a 
Ta
lle
i-U
ns
ra
t) 
2.
 
R
ol
e 
of
 U
SG
 i
n 
O
bs
te
tri
c 
C
ar
e 
to
 R
ed
uc
e 
M
at
er
na
l 
M
or
ta
lit
y 
R
at
e 
an
d 
Pe
rin
at
al
 
M
or
ta
lit
y 
R
at
e 
(P
ro
f. 
D
r. 
I. 
O
. M
ar
si
s, 
Sp
O
G
-
FK
 U
K
I)
 
3.
 
O
pp
or
tu
ni
st
ic
 I
nf
ec
tio
n 
in
 A
ID
S:
 i
m
pa
ct
 o
n 
th
e 
 
liv
es
 
of
 
w
om
en
 
(P
ro
f. 
D
r. 
R
et
no
 
W
ah
yu
ni
ng
si
h,
 S
pP
ar
K
lin
.-F
K
 U
K
I)
 
4.
 
C
ur
en
t 
M
an
ag
em
en
t 
Th
er
ap
y 
in
 
B
re
as
t 
C
an
ce
r: 
Th
e 
R
ol
e 
of
 
PE
T 
C
T 
an
d 
R
ad
io
th
er
ap
y 
w
ith
 R
A
PI
D
 A
R
C
 (
dr
. 
Fi
el
da
 
D
ju
ita
, S
pR
 a
nd
 d
r. 
B
as
uk
i H
id
ay
at
, S
pK
N
) 
R
ep
ro
du
ct
iv
e 
H
ea
lth
 a
nd
 F
am
ily
 P
la
nn
in
g:
 
N
at
io
na
l P
op
ul
at
io
n 
an
d 
Fa
m
ily
 P
la
nn
in
g 
Bo
ar
d 
(B
K
K
BN
) 
M
od
er
at
or
: J
an
ua
r 
Si
m
at
up
an
g,
 S
pO
G
 
1.
 G
ra
nd
 d
es
ig
n 
of
 f
am
ily
 p
la
nn
in
g 
(d
r. 
Po
pp
y 
Ir
aw
at
i, 
M
PH
) 
2.
 C
om
pl
ic
at
io
ns
 d
ur
in
g 
de
liv
er
y 
ba
se
d 
on
 I
D
H
S 
20
07
 (d
r. 
N
ia
 R
ev
ia
ni
, M
A
PS
) 
 
Proceeding Seminar
Women & Health: Towards a better understanding and environment for the future 5
aGo buku uki.indd   5 1/23/2016   5:09:26 PM
W
om
en
 in
 E
du
ca
tio
n 
 
3.
 D
r. 
Ill
ah
 S
ai
la
h 
(D
G
H
E-
M
O
E)
 
4.
 D
r. 
Se
ty
o 
Pe
rti
w
i (
IP
B
) 
M
od
er
at
or
:  
G
an
da
 H
ut
ap
ea
, S
E,
 M
B
M
 
 
 *I
nd
os
ta
ff
: i
s a
n 
al
um
ni
 o
rg
an
iz
at
io
n 
w
ho
se
 
m
em
be
r i
s p
ar
tic
ip
an
ts
 o
f D
IE
S-
D
A
A
D
’s
 
co
ur
se
s, 
na
m
el
y:
 U
N
IS
TA
FF
, U
N
IL
EA
D
 
an
d 
In
te
rn
at
io
na
l D
ea
ns
’ C
ou
rs
e 
(I
D
C
). 
Fr
id
ay
,  
25
 N
ov
 
08
:3
0-
12
.3
0 
In
do
st
af
f F
or
um
 
  
W
om
en
 in
 H
ig
he
r 
E
du
ca
tio
n 
 
1.
 P
uj
i M
ud
ia
na
, M
A
. 
2.
 D
r. 
Ie
d 
V
ed
a 
Si
te
pu
, M
A
. 
M
od
er
at
or
: D
r. 
A
pr
ili
an
a 
La
ily
 F
itr
i (
U
N
J)
 
12
.3
0-
13
.3
0 
Lu
nc
h 
13
.3
0-
15
.0
0 
G
ro
up
 w
or
ki
ng
 
15
.0
0-
16
.0
0 
Ev
al
ua
tio
n 
&
 F
ol
lo
w
-u
p 
pl
an
ni
ng
 
16
.0
0-
16
.3
0 
C
lo
si
ng
 o
f t
he
 W
or
ks
ho
p 
 
 
 
 
15
.3
0-
16
.0
0 
 
C
lo
si
ng
 c
er
em
on
y 
 
   W
 o
 r
 k
 s 
h 
o 
p 
 W
ed
ne
sd
ay
, 
23
 N
ov
  
08
:3
0-
12
.3
0 
W
or
ks
ho
p 
1:
  
H
ow
 to
 d
ev
el
op
 a
 g
en
de
r-
se
ns
iti
ve
 h
ea
lth
 p
ro
gr
am
 in
 p
oo
r-
se
tti
ng
 a
re
as
. 
Fa
ci
lit
at
or
s:
  
1.
 D
r. 
B
rit
ta
 T
he
ge
 (C
en
te
r o
f W
om
en
 S
tu
dy
 –
 U
ni
v 
of
 A
pp
lie
d 
Sc
ie
nc
e,
 K
ie
l) 
2.
 A
lp
hi
nu
s K
am
bo
dj
i, 
M
D
 (A
ID
S 
C
om
m
itt
ee
 –
 In
do
ne
si
an
 C
ou
nc
il 
of
 C
hu
rc
he
s)
  
3.
 E
vi
 D
ou
re
n,
 M
D
 
12
.3
0-
13
.3
0 
Lu
nc
h 
12
.3
0-
16
.0
0 
H
ow
 to
 d
ev
el
op
 a
 g
en
de
r-
se
ns
iti
ve
 h
ea
lth
 p
ro
gr
am
 in
 p
oo
r-
se
tti
ng
 a
re
as
. 
 
D
A
TE
 
T
IM
E
 
P 
R
 O
 G
 R
 A
 M
 
Th
ur
sd
ay
, 
24
 N
ov
 
08
:3
0-
12
.0
0 
W
or
ks
ho
p 
2:
 K
eg
el
 
ex
er
ci
se
 to
 st
re
ng
th
en
 th
e 
pe
lv
ic
 m
uc
le
s o
f 
m
ul
tip
ar
a 
w
om
en
 
(F
ac
ili
ta
to
rs
: D
ra
 S
ri 
K
us
tin
i S
ST
 F
t, 
M
 F
is
. a
nd
 
M
ak
si
m
us
 B
is
a,
 S
St
FT
, 
SK
M
)  
W
or
ks
ho
p 
3:
 
D
em
on
st
ra
tio
n:
 T
at
to
o-
re
m
ov
al
 
(F
ac
ili
ta
to
r: 
dr
. A
go
 H
ar
lim
, 
Sp
K
K
, M
A
R
S)
 
     A
rr
iv
al
 o
f I
nd
os
ta
ff
 F
or
um
 P
ar
tic
ip
an
ts
 
 
12
.3
0-
13
.3
0 
Lu
nc
h 
 
13
.3
0-
18
.0
0 
In
do
st
af
f F
or
um
* 
 
Women & Health: Towards a better understanding and environment for the future
Proceeding Seminar
6
aGo buku uki.indd   6 1/23/2016   5:09:26 PM
Term of Reference DIGM-GIMA:
Deutsch-Indonesische Gesellschaft für Medizin -  
German Indonesian Medical Association
 
Indonesian Chapter
Firstly introduced on 21 July 1996 in Jakarta in accordance with an 
International Medical Symposium for German Alumni organized by 
Deutscher Akademischer Austausch Dienst (DAAD).  DIGM was officially 
established on 18 November 1997.
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The founders  of DIGM were (among others): Prof. Dr.med Bundschu, Dr. 
H. Seeman (the German Ambassador in Indonesia), Dr. Hot Asi Napitupulu, 
SpBS (†), Dr. RT Purba, SpBKV (†), Dr.med. J. Tangkudung, Dr. Henry 
Naland, SpBOnk., Dr.med. Abraham Simatupang, MKes., Prof. Dr. H.J. 
Freisleben. DIGM is officially registered under Notary Act: SK. Menkeh 
No: C-413.4T.03.01-1999, 12 December 2000 No. 3.
On its establishment, the Board Members were chosen among these who 
established the organization. They started the organization deliberately 
with programs.  
Board of Committee  
(1997-2002)
• President:  Dr. med.  Hot Asi Napitupulu, Sp. BS
• Secretary:  Dr. med. Abraham Simatupang, MKes
• Members:  Prof. Dr. H.J. Freisleben
  Dr. Silvester Wirjanto
  Dr. Henry Naland
  Dr. med. Santoso Adhiwana
  Dr. Biol. Nelson Simanungkalit
Women & Health: Towards a better understanding and environment for the future
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Regional Coordinators
• Medan (North Sumatera): Dr.med. Y. Siregar
• P. Siantar (North Sumatera): Dr.med. P. Girsang
• Padang (West Sumatera): Dr.med. Eryati D. Arwin
• Bandung (West Java): Dr.med. Alwin Wulur
• Yogyakarta: Dr. med. Widharto PH.
• Surabaya: Prof. Dr. Puruhito
• Ujung Pandang: Dr. Syarifuddin Rauf
• Denpasar (Bali): Dr. I Made Sudewi
In the beginning, DIGM organized scientific activities, such as, a workshop 
on neurosurgery, in cooperation with the Department of Neuro Surgery, 
School of Medicine of Universitas Pajajaran, Bandung; a symposium on 
Updates of Modern Medicine in cooperation with the School of Medicine 
of Universitas Kristen Indonesia, Jakarta; and Seminar on Cardiovascular 
Medicine and Health Insurance in cooperation with P.T. Askes (State 
Health Insurance Company).
In 2002, the President of DIGM, Dr. Napitupulu passed away, and Dr. 
Simatupang took over the chairmanship. 
To be more professional, Global Medica, led by Ms. Hanny Moniaga, was 
appointed to become partner in organizing scientific and cultural events. 
With this partnership, many activities are organized successfully. 
DIGM organizes Annual and Biannual Scientific Meetings, where 
Indonesian and German experts exchange knowledge and experiences. 
Aside from regular meetings, DIGM also gives opportunities to its 
members to pursue internship and further trainings in Germany.
Through exchange programs DIGM Indonesia sent dr. Sahala Panggabean, 
Sp.PD to Caritas Krankenhaus to have 6-month training on renal. The stay 
was organized by Prof. Dr.med. H.D. Bundschu. Also dr. S.P. Gultom had 
the same experience. He learned Gastroscopy at Caritas Krankenhaus.
 
Board of Committee  
(2002-October 2006)
President : Dr.med. Abraham Simatupang, MKes
Vice Presidents : Dr. Henry Naland, SpBOnk.,
Proceeding Seminar
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   Dr. Liem Kian Hong, SpB
Secretary : Dr. Sahala Panggabean, SpPD.
Vice Secretary : Dr.med. Adenan Irianto, SpPD
Vice Secretary : Dr.med. Sylvester Wiryanto
Treasurers : Dr.med. Linda Rachmat  
   Dr.med. Waldemar Simanjuntak, SpPD.
•	 Advisory Board: 
Prof. Dr. Reiner Koerfer, Prof. Dr. Chris B Lumenta, Prof. Dr. HD 
Bundschu, Prof. Dr. Hehrlein, Prof. Dr. Ulrike Blum, Prof. Dr.med. 
Puruhito, Prof. Dr. Molls, Prof. Dr. Djoko Rahardjo, Prof. Dr. Wiguno 
P, Prof. Dr. Arry Haryanto, Dr. Daniel Makes SpRad., Prof. Dr. T. 
Santoso, SpPD, FACC, Prof. Dr. Ali Sulaiman, PhD., Prof. Dr. HJ 
Freisleben.
•	 Chief	Organizing	Officer:
Ms. Hanny Moniaga
•	 Scientific Committee (among others):
Dr. Akmal Taher, Dr. Rainy Umbas, Prof. Dr. Paul Tahalele.
•	 Publication:
Dr. Sonya Leonardi, SpPD, Dr. Karel D Saragih, SpPD, Dr. SP 
Gultom, SpPD.
•	 Regional Chairpersons:
Dr.med. Andi Permadi (Bandung), Prof. Dr. Paul Tahalele (Surabaya), 
Dr. Santoso Adhiwana (Jakarta), Dr.med. Widharto Ph. (Yogyakarta).
In this era, DIGM  took also an active role in many health aspects in the 
country. In February 2005, Dr.med. Abraham Simatupang took a 2-week 
mission to Banda Aceh on a humanitarian relieve action for Tsunami’s 
victims who were estranged in remote areas. They moved to their closest 
families after receiving emergency care from Red Cross and other relieves 
NGOs. Because their houses and belongings were vanished by Tsunami 
Women & Health: Towards a better understanding and environment for the future
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and they were unwilling to stay longer in the camps, therefore, they moved 
to their families. Together with the local volunteers, Dr. Simatupang and 
the team had home visit and gave them medical and psychological aids 
they needed. When Dr. Simatupang was in Sigli, he also sent a child who 
had a hernia to the German Military Mobile-Hospital in Banda Aceh and 
the child was successfully operated by the team doctors of the German 
Military Mobile-Hospital.
As Dr.Heston Napitulu from Universitas Kristen Indonesia asked DIGM 
Indonesia to help him for an opportunity to take specialization in heart 
surgery, we referred the intention to DIGM German Chapter and we 
received a positive response from Prof. Dr. Rainer Koerfer who gladly 
gave Dr. Napitupulu the place (Stelle).
In the board meeting of DIGM-Indonesian Chapter, held on 5 March 2006, 
Dr.med. Liem Kian Hong, SpBTKV, was elected President. 
Board of Committee  
(October 2006-September 2008)
President : Dr. Liem Kian Hong, SpB
Vice Presidents : Dr. Henry Naland, SpBOnk.
   Dr.med. Santoso Adhiwana, SpJP.
Treasurers : Dr.med. Linda Rachmat 
   Dr.med. Waldemar Simanjuntak, SpPD, KGE.
Chief Organizing Officer: Ms. Hanny Moniaga
Strategic Plan
Vision: 
To be a respected medical association which deals with  advancements of 
medicines, empowerment of the medical personnel for the betterment of 
the society
Mission Statements:
1. To promote medical professionalism through advancement of 
medical science and ethics
2. To establish networking with both national and international medical 
Proceeding Seminar
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science communities and medical associations.
3. To deliver a better and quality service to the community
4. To promote expert exchange programs and continuing medical 
education
Strategies:
• Networking:
1. Embassies of the Republic of Indonesia in Germany and the 
Republic of Germany in Indonesia
2. Indonesian Medical Association (IMA/IDI)
3. Department of Health of the Republic of Indonesia
4. Other Indonesian Medical Profession Associations
5. Medical Faculties
6. NGOs.
• Expanding membership (not only open to German alumni but also 
alumni from other universities or institutions in Indonesia and 
European countries).
Activities:
• Workshop on Neurosurgery at the School of Medicine – Universitas 
Pajajaran, Bandung (West Java).
• Simposium on Modern Medicine (in cooperation with the Faculty 
of Medicine – UKI).
• Seminar on Cardiovascular & Health Insurance, Jakarta
• Seminar on Organ Transplantation, Jakarta.
• Seminar on Traumatology, Pematang Siantar (North Sumatera).
• Seminar on Oncology, Jakarta.
• Seminar on New Discoveries in Cardiovascular Disease and 
Treatment in Jakarta (a “farewell” seminar to H.E. Dr. H. Seeman, 
Ambassador of Germany in Indonesia)
• Annual Scientific Meeting: Update on Multidisciplinary 
Management of Cancer. Seminar & Workshop: “Color Doppler 
Flow Imaging in Liver Tumor (Jakarta, 9-11 August 2002).
• 2nd Annual Scientific Meeting:  Updates on Obstetrics & 
Women & Health: Towards a better understanding and environment for the future
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Gynecology & Urology (Jakarta, 23-24 August 2003).
• Earthquake & Tsunami Humanitarian Relief Actions in Aceh 
and Nias  from January-February 2005 and March 2005 (in 
coordination with NGOs)
• Short courses: Dr. Panggabean in Caritas Krankenhaus in Bad 
Mergentheim; Dr. Gultom in Wuppertal.
• Scholarships: Dr. Heston Napitupulu in Herz & Diabetes Zentrum 
– Bad Oeynhausen for Heart-Surgery specialist.
• Publications: 5 Proceedings for Symposia and Seminars, 1 scien-
tific journal (DIGM Medical Journal) published biannually (Jan.-
June & July – Dec.), and since February 2011 – DIGM Medical 
Journal has a strategic partnership with Medical Journal of Indo-
nesia – Faculty of Medicine – University of Indonesia.
Further planned Activities:
• Expert exchange programs
• Seminars and Conferences
• Celebration for Christmas, New Years, Ramadhan And Oktoberfest
• 2008: Indo-Germa Health Expo
List of sponsors and contributors
• DAAD – German Academic Exchange Service
• PT Astrindo
• Glaxo Smith and Kline (gsk)
• MRCCC-Siloam Hospitals
• PT Bina Rupa Aksara (Toko Buku Karisma)
• BKKBN
• PT Kalbe Farma
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Portraits of Breast Cancer Survivor
Whom  With Surrender But Endeavor
Full  Of Passion  & Persistence For Healing
In The Midst  Of   POVERTY  And   IGNORANCE
Maria Goretti Ametembun
Internal Medicine Dept. of Emma Poeradiredja 
Maternity Hospital, Bandung.
Emma Poeradiredja Hospital,  
Jl. Sumatera 46-48 Bandung 40113, Indonesia.
E-mail: margotstefie@yahoo.com;	mg.ametembun@gmail.com
Sex-linked Effects of Pharmacotherapy
Abraham Simatupang
Department of Pharmacology and Therapy – Faculty of Medicine 
Universitas Kristen Indonesia
Abstract
After rigorous pre-clinical trials on cells, organs and animals had been done 
to a promising active substance, it is usually followed by clinical trial which 
uses human. Clinical trial comprises of three phases and one trial called 
post-marketing surveillance and each phase has its own objectives and 
characteristics.  Efficacy and safety are two important factors for judging 
and reviewing new drugs in clinical trials. In phase one, as the drug for the 
very first time is applied to human body, (young) men are recruited and used 
particularly to determine pharmacokinetics (PK) and pharmacodynamics 
(PD) profiles of the drug. In phase two and three the drug are tested in 
patients to proof the efficacy and safety of the drug.  Unfortunately, in 
most clinical trials, especially in early development phases, women were 
often not substantially recruited. Therefore, women are underrepresented 
in clinical trials to show the efficacy and safety issues of new drugs. The 
backgrounds for not recruiting women in clinical trials are many, among 
others are due to the possibility of toxic effects on reproductive system. 
The teratogenicity of thalidomide in the 60s, which then was approved for 
anti-emesis of pregnant women, made many drug regulatory bodies strictly 
forbid to include women in reproductive phase to be included in clinical 
trial. However, when the drug is released and used in the market, it will be 
also prescribed for women and adverse drug reactions can emerge. Some 
reports show that women are more likely experience adverse events than 
men have been increasing. Therefore, appeals and advocacy for increasing 
the number of women in clinical trials have been increased recently. This 
article discusses the pros and cons of carrying out clinical trials in women.
Keywords: clinical trial, gender, pharmacokinetics, pharmacodynamics, 
efficacy, safety 
Sex-linked Pharmacodynamics-Pharmacokinetics differences of 
Drugs’ Effects
The “Thalidomide tragedy” in late 50s and early 60s was indeed a hard 
punch for pharmacy industry and the development of drugs. Since then 
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women has been excluded in most of clinical trials done between 60s until 
90s, regardless of their sexual activity, sexual orientation, etc. – for fear 
of causing fetal harm.1-2 But in late 90s several women organizations and 
activists advocated and pushed that more women should be included in 
clinical trials especially for drugs to treat conditions that affected women. 
This was followed by formulating guidance and policies by National 
Institute of Health (NIH) in the US for the inclusion of women in clinical 
trials.1 Biological differences between men and women could also 
determine the pharmacokinetics and pharmacodynamics effects of certain 
drugs, as it is showed in many studies. 3-5
One comprehensive study on the effect of gender in pharmacotherapy 
was done by Yerman, Gan and Sin. 3 They did a comprehensive literature 
study, comprised of 23 trials (n= 113,494 participants) on the effects of 
aspirin in preventing myocardial infarction (MI). It shows that despite the 
overall good results of aspirin compared to placebo, a total of 27% of the 
variation in the non-fatal MI results could be accounted for by considering 
the gender mix of the trials (p = 0.017). Trials that recruited predominantly 
men demonstrated the largest risk reduction in non-fatal MI (RR = 0.62, 
95% CI 0.54–0.71), while trials that contained predominately women 
failed to demonstrate a significant risk reduction in non-fatal MI (RR = 
0.87, 95% CI 0.71–1.06).
The answer to question of why the pharmacokinetics of drugs in women 
could show differently from men is based by the two pharmacokinetics 
indicators i.e. volume distribution (Vd) and clearance (Cl) which are 
dependent on body weight. Generally, women weigh less than men, 
therefore, women are more likely receiving higher doses, since dosage-
finding studies usually done in men.4
According to Soldin et al.5 there are at least three reasons of sex-difference 
with regards to adverse events that can arise from medicaments taken by 
women, as is suggested in Table 1 (see below).
Table 1. Suggested reasons for sex differences in adverse event reporting (Soldin, 
et al. 2011)5
Women & Health: Towards a better understanding and environment for the future
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As it is seen from Table 1, numerous pharmacological factors are intertwined 
which can bring difficulties for us to determine which was the main factor 
that would cause the adverse reactions apart from their therapeutics effects.
 
Pharmacokinetics factors in women
Pharmacokinetics (PK) is defined as “what body does/acts on drugs” 
or is about the “fate of the drugs”, which actually comprises of 
absorption, distribution, metabolism and excretion (ADME) of the 
drugs. All of these factors are also, according to the recent studies, 
determined by sex.4-7  Many theoretical approaches have been used 
to describe or predict differences of absorption of drugs between 
men and women, such as, women have lower organ blood flow, 
that may slowing the rate of absorption.8 It has been reported that 
some hormones may modify gastric acid secretion, and therefore 
gastric pH, and additionally, a slower gastric emptying time is 
present in females.9-10   On distribution, it is well known that there 
are some differences between men and women. Women have lower 
average body weight, higher body fat percentage, smaller average 
plasma volume and lower average organ blood flow than men11-13 
One important thing to consider is the protein binding, since major 
protein that are responsible for binding the drugs are also influenced 
by sex-hormones, which fluctuate during the menstrual cycle. As a 
result, important distribution differences are observed.13-14
Metabolism is the main subject that draws a lot of attention 
regarding the sex-linked differences in pharmacokinetics of drugs. 
Metabolism consists of two reactions, named Phase I and Phase II, 
and both are enzymatic reactions. Phase I reactions are oxidation, 
reduction and hydrolysis, whereas Phase II are acetylation, sulfation, 
glucuronodation and methylation.  The most profound oxidative 
enzyme in phase I is cytochrome P-450 (CYP) which also has many 
isozymes. It has been reported that CYP3A4 is the major isozyme 
of this enzymatic pathway and is responsible of the metabolism of 
about 50% of the current used drugs.4 Debated results have been 
published concerning the activity of this enzyme. Several authors 
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have suggested (based on in vitro studies) that CYP3A4 activity is 
higher in women than in men, while CYP1A2 and CYP2D6 activity 
is higher in men, and no variances or conflicting results have been 
reported in other CYPs. Some in-vitro findings, which sometimes 
are not consistent with in-vivo results, showed like CYP1A2 that is 
responsible for metabolism of drugs including clozapine, olanzapine, 
theophylline and ondansetron. This isozyme is highly activated in 
smokers, therefore, we can predict that the concentration of afore 
mentioned drugs are higher in women than in men, while men usually 
are smokers. Other polymorphic isozyme named CYP2C9 is also 
responsible for metabolism of wide variety drugs like phenytoin, 
several non-steroidal anti-inflammatory drugs (NSAIDs, piroxicam, 
diclofenac, and ibuprofen) and sulfonylureas (glimepiride, glipizide 
and glyburide). Although this isozyme is polymorphic, but there 
is no gender specific difference regarding the metabolism activity, 
except for phenytoin, as reported by Meyer et al.15 Carrasco-Portugal 
and Flores-Murrieta has compiled the differences of some important CYP 
isozymes as it is shown in Table 2.4
Regarding the excretion, glomerular filtration rate (GFR) of women 
is lower than men; moreover, after normalizing GFR by the body 
size, a 10% difference is still seen. Therefore, renal clearance may 
be reduced for a wide variety of drugs.16
Table 2. Comparative activity of different enzymatic path- ways between genders.4
These characteristics leads to sex-related differences in the pharmacokinetics 
that brings the reduction of bioavailability and therefore to a different 
pharmacodynamic profile. Pharmacodynamics changes can affect both the 
Women & Health: Towards a better understanding and environment for the future
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desired therapeutic effect of a drug as well as its adverse effect profile.
As concequences of changes in PK profiles of drugs which lead to the 
change of effects, we sometimes have to alterate the dosage or take an 
extra precautions to the unwanted effects that might occur. 
Table 3. Differences in Medication Effects between Women and Men6
Herbal medicine and conventional medicine
Use of herbal medicine has been growing for the last 20 years in Indonesia. 
Many pharmaceutical industries are also started to produce herbal medicines 
or they developed herbal medicine departments which concentrated on 
research and developing new preparations of herbal medicines. Usually, 
the pharmacy industries focus only on following the standardization and 
quality procedures for planting, harvesting, and manufacturing of herbal 
medicines required by the authorities.  Furthermore, they do some clinical 
research to get clinical evidence for new indications that is different from 
the previous traditional use of the herbs. Although most of the herbal 
medicines are claimed safe and used only for prevention and health 
maintenance, however, there is still lack of clinical research or reports on 
the advantageous or unwanted effects of concomitant use of herbal and 
conventional medicine in patients with particular conditions or ailments. 
Therefore, there are a lot of subjects to study regarding the sex-linked 
differences of pharmacotherapy.
Conclusion
The pharmacokinetics and pharmacodynamics relationship in correlation 
with sex of many drugs are not always clear. Many contributing factors like 
physiological and pathological condition of the subjects are influencing 
this phenomenon. However, it seems that an important contribution for 
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observing higher levels in women is that usually doses employed in women 
are higher than in men when they are normalized by the body weight.
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INDOSTAFF Forum: Women in Education
Women  participation  in  all  aspects  of  life  is  lower  than  men.  They 
still  are  considered  as  the second class, and the chance to get involve by 
most of the women is low, due to several causes. 
One crucial cause is education – from the lowest into the highest stake 
of education. The myth that still exists is woman are born only to rear 
her family and be busy with domestic things only –  a  scientific  or  an 
official  career  for  most  of  the  women  are  only  dreams  that  can 
not  be fulfilled. However, interestingly, there are more women and baby-
girls have been born during the last twenty years, and the women life-
expectancy is higher than  men. Meaning, there are abundant opportunities 
available for women to decrease the gaps and to increase the accessess that 
finally can increases some importants parameters that have been choosen 
as indicators for a  healthy  nation.  These  parameters  are  put  into 
Millenium  Development  Goals  (MDGs).  Four out of 8 goals of MDGs 
are closely related with women, especially the Goal 3: Promote gender 
equality  and  empower  women,  Goal  4:  Reduce  child  mortality  and 
Goal  5:  Improve  maternal health. Again these goals can only be achieved 
by educating and empowering women who will take greater role and 
responsibility to build a stronger nation.
Indostaff  is  an  alumni  organization  born  in  2010  as  an  amalgam  of 
three  DIES-DAAD’s supported  university  staff  development  programs, 
namely  UNISTAFF,  International  Deans’ Course and UNILEAD. The 
main purpose of the Indostaff is to increase and maintain the quality of  the 
higher  education  in  Indonesia  through  collaboration  and  partnership 
with  government and private universities as well as governing bodies of 
the higher education such as Directorate General of Higher Education 
(DGHE), German Academic Exchange Service (DAAD), etc.
Indostaff has been called to be actively involve for nurturing and increasing 
the quality of the higher  education  and  this  has  been  showed  by  doing 
some  activities  such  seminar  and workshops  either  organized  by 
Indostaff  alone  or  together  with  DGHE,  DAAD,  University  of Indonesia, 
Universitas  Gajah  Mada,  Institut  Pertanian  Bogor,  Universitas  Sam 
Ratulangie, Universitas Brawijaya, Universitas Kristen Indonesia, etc. 
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 Objectives:  
1. To  discuss  and  gather  ideas  about  contribution  of  women  in 
(higher)  education  with regards to teaching and learning, research 
and community service. 
2. To  map  opportunities  and  challenges  of  women  in  higher 
education  institutions  in implementing the MDGs in their respective 
expertise and areas of knowledge. 
3. To  strengthen  the  Indostaff  membership  cultures  based  on  mutual 
inter-disciplinary approaches on higher education issues.
Women & Health: Towards a better understanding and environment for the future
Proceeding Seminar
140
aGo buku uki.indd   140 1/23/2016   5:09:37 PM
Proceeding Seminar
Women & Health: Towards a better understanding and environment for the future 141
aGo buku uki.indd   141 1/23/2016   5:09:38 PM
aGo buku uki.indd   142 1/23/2016   5:09:38 PM

W
o
m
e
n
 &
 H
e
a
lth
: To
w
a
rd
s a
 b
e
tte
r u
n
d
e
rsta
n
d
in
g
 a
n
d
 e
n
viro
n
m
e
n
t fo
r th
e
 fu
tu
re
 
 
Deutsch Indonesische 
Gesellschaft fuer Medizin
 
DAAD Deutscher Akademischer Austausch DienstGerman Academic Exchange Service
DEUTSCHLAND UND 
INDONESIEN 
kreativität in vielfalt 
Women & Health: Towards a better 
understanding and environment for the future 
PROCEEDING SEMINAR
21-24 November 2011
Auditorium Grha William Soeryadjaya
Campus FK UKI – Cawang – Jakarta - Indonesia
Editor: Abraham Simatupang
Britta Thege
Erika Ferrari
Eva Suarthana
ISBN 978-602-1651-68-1
9 786021 651681
Penerbit: 
Fakultas Kedokteran 
Universitas Kristen Indonesia (UKI)
